Paul B Cleveland - Net Worth and Insider Trading

Paul B Cleveland Net Worth

The estimated net worth of Paul B Cleveland is at least $0 dollars as of 2024-11-13. Paul B Cleveland is the Director of Sangamo Therapeutics Inc and owns about 0 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $0. Details can be seen in Paul B Cleveland's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul B Cleveland has not made any transactions after 2014-01-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Paul B Cleveland

To

Paul B Cleveland Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul B Cleveland owns 5 companies in total, including Alder BioPharmaceuticals Inc (ALDR) , Adverum Biotechnologies Inc (ADVM) , and Sangamo Therapeutics Inc (SGMO) among others .

Click here to see the complete history of Paul B Cleveland’s form 4 insider trades.

Insider Ownership Summary of Paul B Cleveland

Ticker Comapny Transaction Date Type of Owner
ALDR Alder BioPharmaceuticals Inc 2019-10-22 director
ADVM Adverum Biotechnologies Inc 2015-12-09 director & President and CEO
SGMO Sangamo Therapeutics Inc 2015-06-22 director
LIMIT LIMIT 2014-06-19 President and CFO
LIMIT LIMIT 2010-09-22 EVP & Corp. Development and CFO

Paul B Cleveland Latest Holdings Summary

Paul B Cleveland currently owns a total of 1 stock. Paul B Cleveland owns 0 shares of Sangamo Therapeutics Inc (SGMO) as of January 15, 2014, with a value of $0.

Latest Holdings of Paul B Cleveland

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGMO Sangamo Therapeutics Inc 2014-01-15 0 2.71 0

Holding Weightings of Paul B Cleveland


Paul B Cleveland Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul B Cleveland has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 8,333 shares on January 15, 2014, which brought Paul B Cleveland around $155,660.

Insider Trading History of Paul B Cleveland

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul B Cleveland Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Paul B Cleveland Ownership Network

Ownership Network List of Paul B Cleveland

No Data

Ownership Network Relation of Paul B Cleveland

Insider Network Chart

Paul B Cleveland Owned Company Details

What does Alder BioPharmaceuticals Inc do?

Who are the key executives at Alder BioPharmaceuticals Inc?

Paul B Cleveland is the director of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and Chief Financial Officer Carlos Campoy .

Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alder BioPharmaceuticals Inc Insider Transactions

No Available Data

Paul B Cleveland Mailing Address

Above is the net worth, insider trading, and ownership report for Paul B Cleveland. You might contact Paul B Cleveland via mailing address: C/o Affymax, Inc., 4001 Miranda Ave., Palo Alto Ca 94304.